Invent Medic Sweden AB (XSAT:IMS) FCF Margin %: -80.91% (As of Mar. 2026)

What is Invent Medic Sweden AB FCF Margin %?

Invent Medic Sweden AB XSAT:IMS 38 FCF Margin % is -80.91% as of Mar. 2026. GuruFocus rates XSAT:IMS with a GF Score™ of 38/100 and a GF Value™ of kr0.18 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Invent Medic Sweden AB ranks worse than 81.35% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Invent Medic Sweden AB's Free Cash Flow for the three months ended in Mar. 2026 was kr-1.67 Mil. Invent Medic Sweden AB's Revenue for the three months ended in Mar. 2026 was kr2.06 Mil. Therefore, Invent Medic Sweden AB's FCF Margin % for the quarter that ended in Mar. 2026 was -80.91%.

As of today, Invent Medic Sweden AB's current FCF Yield % is -28.84%.

The historical rank and industry rank for Invent Medic Sweden AB's FCF Margin % or its related term are showing as below:

XSAT:IMS' s FCF Margin % Range Over the Past 10 Years
Min: -26585.37 Med: -707.19 Max: -62.6
Current: -67.85

During the past 10 years, the highest FCF Margin % of Invent Medic Sweden AB was -62.60%. The lowest was -26585.37%. And the median was -707.19%.

XSAT:IMS's FCF Margin % is ranked worse than
81.35% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.03 vs XSAT:IMS: -67.85

Invent Medic Sweden AB FCF Margin % Related Terms

Invent Medic Sweden AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Invent Medic Sweden AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invent Medic Sweden AB FCF Margin % Chart

Invent Medic Sweden AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-996.66

-417.71

-104.29

-104.93

-62.60

Invent Medic Sweden AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-60.00	-76.33	-90.98	-19.81	-80.91

XSAT:IMS vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Invent Medic Sweden AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invent Medic Sweden AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's FCF Margin % falls into.

Save Embed

38GF Score

Invent Medic Sweden AB XSAT:IMS

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Invent Medic Sweden AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Invent Medic Sweden AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-4.635	/	7.404
	=	-62.60 %

Invent Medic Sweden AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-1.666	/	2.059
	=	-80.91 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -80.91% mean?

Invent Medic Sweden AB (XSAT:IMS) has a FCF Margin % of -80.91% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Invent Medic Sweden AB and its competitors. According to the industry distribution chart, Invent Medic Sweden AB ranks #663 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 81.3%.

Is Invent Medic Sweden AB's FCF Margin % too high?

Invent Medic Sweden AB's current FCF Margin % is -80.91%. Based on the distribution chart, Invent Medic Sweden AB ranks #663 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Invent Medic Sweden AB has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Invent Medic Sweden AB's FCF Margin % compare to ABT and SYK?

According to the Medical Devices & Instruments industry distribution chart, Invent Medic Sweden AB ranks #663 out of 815 companies for FCF Margin %. This places Invent Medic Sweden AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Devices & Instruments company?

A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Invent Medic Sweden AB and its competitors. Invent Medic Sweden AB's current FCF Margin % is -80.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Invent Medic Sweden AB stock overvalued right now?

Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.13 — trading 25.6% below its estimated fair value. The current FCF Margin % is -80.91%. Invent Medic Sweden AB's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current FCF Margin % is -80.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Invent Medic Sweden AB (XSAT:IMS) Overvalued in 2026?

Based on GuruFocus' analysis, Invent Medic Sweden AB stock appears to be undervalued. The current stock price of kr0.13 is trading 25.6% below its estimated GF Value™ of kr0.18. GuruFocus considers Invent Medic Sweden AB to be Modestly Undervalued.

Key valuation signals for XSAT:IMS:

FCF Margin %: -80.91%
GF Value™: kr0.18 vs. price of kr0.13 (25.6% below fair value)
GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the XSAT:IMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Invent Medic Sweden AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XSAT:SDET OSTO:LXB XSAT:ISAB XSAT:MONI XSAT:ZENI XSAT:PEXA B OSTO:PERP B XSAT:VSD B XSAT:POLAR OSTO:SPEC ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Address Nytenkargatan 4, Lund, SWE, 223 63

Website http://www.inventmedic.com

Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

38GF Score

Get the complete analysis for XSAT:IMS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.13

Price

kr0.18

GF Value

View XSAT:IMS Analysis

See FCF Margin % data for all stocks →